UNITED THERAPEUTICS Corp (UTHR) stock
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3025% above fair value
$591.17−2.14 (-0.36%)
Close on Nov 13, 2026Market cap $25.36BP/E 22.3Yield –
United Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
United Therapeutics's EV/EBITDA was 15.2× on Nov 11, 2026, against 11.5× a year earlier. Over the last 5 years it ranged from 6.1× to 15.4×, with a median of 8.8×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 15.2× | +3.7 |
| 2025 | Dec 31, 2025 | 11.5× | +2.3 |
| 2024 | Dec 31, 2024 | 9.2× | +2.8 |
| 2023 | Dec 29, 2023 | 6.5× | −3.3 |
| 2022 | Dec 30, 2022 | 9.8× | −5.6 |
| 2021 | Dec 31, 2021 | 15.4× | +7.3 |
| 2020 | Dec 31, 2020 | 8.1× | +4.4 |
| 2019 | Apr 30, 2019 | 3.6× | −0.5 |
| 2018 | Dec 31, 2018 | 4.1× | −1.7 |
| 2017 | Dec 29, 2017 | 5.9× | +1.1 |
| 2016 | Dec 30, 2016 | 4.8× | −3.6 |
| 2015 | Dec 31, 2015 | 8.4× | −7.1 |
| 2014 | Dec 31, 2014 | 15.6× | +4.3 |
| 2013 | Dec 31, 2013 | 11.3× | +4.6 |
| 2012 | Dec 31, 2012 | 6.7× | −1.9 |
| 2011 | Dec 30, 2011 | 8.6× | −11.0 |
| 2010 | Dec 31, 2010 | 19.6× | – |
See a number that looks wrong?